Search concepts
|
Selected filters
|
- 450 - 500 out of 19,095 results
- Export search results
Search results
-
Active
An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1 Study of IMU- 201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer [IMU201-101].
Richardson, G. & Baker, E.
14/10/20 → 31/12/22
Project: Research
-
Australian Government's Blueprint for Deepening Trade and Investment in Indonesia - Education, Training and Skills Sector
Sebastian, E.
Department of Foreign Affairs and Trade (Australia)
14/10/20 → 30/06/21
Project: Research
-
ARDC Data Retention Project Phase 1: Existing Collections
Quenette, S., Soo, A., Kannan, A., Groenewegen, D., Bonnington, P. & Goscinski, W.
13/10/20 → 30/06/23
Project: Research
-
Synthesis, Synergy and Sustainability: Development of active-metal reagents
Australian Research Council (ARC)
12/10/20 → 11/10/24
Project: Research
-
A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/Refractory Myelofibrosis (TRANSFORM-2).
Perkins, A., Kennedy, N., Hamad, N., Chuah, H., Arbelaez, A. & Prasad, R.
12/10/20 → 31/12/25
Project: Research
-
Measuring the benefits of reuse in the circular economy
Lane, R., Yates, J., Grodach, C. & Soker, O.
8/10/20 → 7/10/23
Project: Research
-
Evaluating the subjective experience of cognitive difficulties and objective neuropsychological changes in early menopause (risk reducing bilateral ooperherectomy)
Gurvich, C., Kulkarni, J., Hickey, M., Vincent, A. & White, M.
7/10/20 → 3/12/21
Project: Research
-
A Phase I/II, Open-Label, Multicentre 2-Part Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 as Monotherapy or in Combination in Treatment-Naïve or Relapsed/Refractory Acute Myeloid Leukaemia Patients Not Eligible for Intensive Induction Therapy.
Wei, A. & Kennedy, N.
6/10/20 → 31/12/25
Project: Research
-
A Phase II, 6-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel group trial with a quetiapine arm to evaluate the efficacy, tolerability and safety of oral BI 1358894 in patients with Major Depressive Disorder with inadequate response to antidepressants.
6/10/20 → 31/12/24
Project: Research
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitis.
Sparrow, M. & McKenzie, J.
6/10/20 → 31/12/23
Project: Research
-
An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease.
Bertram, K., Fung, V. S. C., Hayes, M., Stell, R., Kimber, T. E. & Bonke, V.
6/10/20 → 31/12/25
Project: Research
-
Phase I/II, international, multicentre, open-label, non-randomised, non-comparative, study evaluating the safety, tolerability and clinical activity of intravenously administered S64315, a selective Mcl-1 inhibitor, in combination with azacitidine in patients with acute myeloid leukaemia (AML).
Wei, A. & Kennedy, N.
6/10/20 → 31/12/25
Project: Research
-
Robotics and Coding: Enhancing disadvantaged children’s communication and language development
Kewalramani, S., Kidman, G., Tan, H., Kameswaran, K. & Macdonald, S.
5/10/20 → 15/12/21
Project: Research
-
Potential interactions between offshore wind turbines and seabirds
1/10/20 → 1/10/21
Project: Research
-
A randomized, double-blind, dose-ranging, placebo-controlled, Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN 74809 in participants with primary sclerosing cholangitis (PSC) and suspected liver fibrosis (INTEGRIS-PSC).
Roberts, S., Adams, L. A., George, J., Strasser, S. I., Thompson, A. J. V. & Lynch, K.
1/10/20 → 1/11/23
Project: Research
-
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prophylaxis of Migraine in Participants with Episodic Migraine Who Have Previously Failed 2 to 4 Classes of Oral Prophylactic Treatments (ELEVATE).
Hutton, E. & Roos, I.
1/10/20 → 31/10/23
Project: Research
-
Exploiting network vulnerabilities to devise effective combination therapies against breast cancer
Nguyen, L., Abud, H., Schittenhelm, R. & Daly, R.
1/10/20 → 30/11/22
Project: Research
-
Pilot safety and feasibility trial of cell therapies for COVID-19
Malhotra, A., Shehabi, Y., Rogers, B., Lim, R., Wallace, E. & Jenkin, G.
1/10/20 → 30/06/21
Project: Research
-
A game theoretic approach to evolving and analysing mechanism design in WES
Aleti, A., Garcia Gallego, J. & Chong, C. Y.
Facebook, Inc. (United States)
1/10/20 → 30/09/21
Project: Research
-
Targeting renal hypoxia to avoid cardiac surgery associated acute kidney injury
Lankadeva, Y. R., May, C. N., Evans, R. & Cochrane, A.
1/10/20 → 31/12/22
Project: Research
-
A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine
Godfrey, D. I., Purcell, D., Jackson, D., Pouton, C., Lewin, S., Nolan, T., Kedzierska, K., Chung, A. W., Rockman, S. & Shattock, R. J.
1/10/20 → 30/09/22
Project: Research
-
Use of transgenic zebrafish to identify modulators of Z-antitrypsin induced pathology
Bird, P. & Bryson-Richardson, R.
1/10/20 → 30/09/22
Project: Research
-
Improving Rehabilitation Outcomes through Self-Management: My Therapy
Brusco, N., Morris, M. E., Hill, K., Taylor, N. F., Lee, A., Somerville, L., Lannin, N., Abdelmotaleb, R., Callaway, E., Kugler, H., Joy, A., Walpole, B., Boyd, L., Watterson, D. M., Raymond, M. J., Graco, M., Radia-George, C. & Sanfilippo, P.
National Health and Medical Research Council (NHMRC) (Australia)
1/10/20 → 30/09/23
Project: Research
-
Advancing women in healthcare leadership
Teede, H., Skouteris, H., Boyle, J., Riach, K., Homer, C. S. E., Currie, G., Smith, J., Zeps, N., Joham, A., Dhulia, A., Keenen, A. M., Crump, B., Lai, C., Sigston, E., Elston, J., Small, J., Grivell, R. M., Williams, S. & Dufty, T.
National Health and Medical Research Council (NHMRC) (Australia)
1/10/20 → 30/09/24
Project: Research
-
Impacts of COVID-19 on teaching practice and opportunities for virtual internships
Pantic, N., Tsai, Y., Phillips, M. & Gasevic, D.
1/10/20 → 31/01/22
Project: Research
-
COVID-19: Pedagogical Opportunities for students' Online Inquiry-Based-Learning
Kidman, G., Ellis, K., Kewalramani, S. & Tan, H.
1/10/20 → 31/12/21
Project: Research
-
A retrospective case-controlled study to identify clinical predictors of early metastatic disease using PSMA PET imaging (ANZUP1907)
30/09/20 → 30/09/21
Project: Research
-
Shifting the trend in radical battery research
Pas, E., Karton, A., Oyaizu, K. & Yoshizawa-Fujita, M.
30/09/20 → 29/09/23
Project: Research
-
Borderline Personality Disorder as Social Phenomena
Kokanovic, R., Thomas, S., Duff, C., Harris, A., Jones, S., Flore, J., Chanen, A. M., Pollock, S., McCutcheon, L., Blanchard, M. & Rao, S.
29/09/20 → 28/09/23
Project: Research
-
-
An Advanced Multi-Physics Modelling Capability for Material State Awareness
25/09/20 → 25/09/21
Project: Research
-
Uncharted waters: Bluespace connection initiatives for wellbeing, education and planetary health
lisahunter, L. H., Burke, G., Humberstone, B. & Sumartojo, S.
24/09/20 → 30/09/21
Project: Research
-
A phase 1, open-label, dose escalation study of ADG116 in patients with advanced/metastatic solid tumors [ADG116-1003].
Richardson, G. & Baker, E.
24/09/20 → 31/12/23
Project: Research
-
Racial differences in cancer-related mortality and cognitive and physical functioning in ASPREE-XT
Chan, A., Warner, E., Murray, A. & Fitzgerald, S.
23/09/20 → 30/04/21
Project: Research
-
ENZA-p: A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide.
Voskoboynik, M. & Hawkins, C.
22/09/20 → 31/12/25
Project: Research
-
A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared with the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants with Relapsed/Refractory Multiple Myeloma – DREAMM 7.
Spencer, A. & Kennedy, N.
22/09/20 → 31/12/25
Project: Research
-
Understanding the impact of COVID19 during preganancy on the brain development of the child
22/09/20 → 22/09/21
Project: Research
-
TTRACK - Prevalence and characteristics of transthyretin amyloidosis in patients with left ventricular hypertrophy of unknown etiology.
Hare, J. & Downes, R.
21/09/20 → 31/12/21
Project: Research
-
Provision of Behavioural Insights services for a multi-agency behaviour change program focused on community bushfire risk reduction
Boulet, M., Meis-Harris, J. & Plant, B.
18/09/20 → 30/06/21
Project: Research
-
OzGrav Cosmic Explorer Design Study
Thrane, E., Mandel, I. & Lasky, P.
18/09/20 → 18/09/21
Project: Research